Cerebrovascular Flashcards
Mimics of CVA
hypoglycemia, seizures, migraine w/ aura, HTN or Wernicke’s encephalopathy, CNS tumor, drug tox (Li, Phenytoin)
SBP 220 more or DBP 121-140 (non tPA)
aim for 10-15% reduction in MAP. agents: labetolol, nicardipine
Labetolol Dose
10-20 g IV over 1-2 min. May repeat or double q10min. Max 300 mg; cont IV 2-8 mg/min
Nicardipine Dose
5 mg/h cont IV. Titrate by 2.5 mg/h q5-15min to max of 15 mg/h
DBP 140 more (non tPA)
Aim for a 10-15% decr in MAP, agents: nitroprusside
Nitroprusside
0.25-0.5 mcg/kg/min cont IV, inc by same increment, usually up to 2-3 mcg/kg/min; max 10 mcg/kg/min for 10 min, greater - cyanide toxic
SBP 185 more, DBP 110 more (tPA)
Labetolol x 2, Nicardipine; aggressive HTN tx excludes fibrinolytic therapy
BP fibrinolytic therapy
Goal: less than 180/105; DBP 140 more: nitroprusside; SBP 180-230 or DBP 105-140: labetolol, nicardipine
tPA Inclusion
18 yo, acute CVA, timeline est., can begin 3-4.5 hr of CVA onset
tPA Exclusion
Evidence/HO intracranial hemorrhage, cranial hemorrhage or edema, deformities of cranial structure/veins, active internal bleed, plt
tPA relative Exclusion
NIHSS of 25 more, major surgery or serious trauma in prev 14 d, HO GI or UT hemorrhage in prev 21 d, Acute MI prev 3 mos, prego
tPA Exclusion 3-4.5 hrs
80 yo taking oral anticoag regardless of INR, NIHSS or HO both stroke and DM
tPA administration
0.9 mg/kg IV, max 90 mg; 10% over 1 min, 90% over 1 hr, door-to-needle time 60; monitor q15min for 2h then q30min for 6h then q1h for 24 hr, no punctures or anti-coag for 24hr
ICP Goal
cerebral perfusion press - 60-80 mmHG, CPP = MAP - ICP, agents: mannitol, pentobarbital
ICP Supportive Measure
Fluids and/or pressors, packed RBCs (Hct 0-30), PA ctrl, seizure ppx if needed, avoid hyperthermia